Who owns Nephros Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Nephros with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Nephros stock

Who bought or sold Nephros Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Wexford Capital 3.6M $18M 0% Dec 2025
 View chart
Vanguard Group 234k $1.1M -17% Dec 2025
 View chart
Bard Associates 122k $594k -4% Dec 2025
 View chart
Renaissance Technologies 104k $506k 26% Dec 2025
 View chart
Geode Capital Management 75k $364k -2% Dec 2025
 View chart
Cambridge Investment Research Advisors 69k $337k 100% Dec 2025
 View chart
HighTower Advisors 60k $291k 7% Dec 2025
 View chart
Mesirow Financial Investment Management International Equity 50k $244k 262% Dec 2025
 View chart
Essex Investment Management 39k $190k 57% Dec 2025
 View chart
William Blair $ Company 36k $172k 0% Sep 2025
 View chart
Navellier & Associates 27k $133k 100% Dec 2025
 View chart
De Lisle Partners 25k $122k 100% Dec 2025
 View chart
Quadrature Capital 23k $112k 100% Dec 2025
 View chart
Marshall Wace 22k $107k 100% Dec 2025
 View chart
XTX Topco 22k $106k 49% Dec 2025
 View chart
Goldman Sachs Group 19k $93k 2% Dec 2025
 View chart
Citadel Advisors 17k $78k 39% Sep 2025
 View chart
State Street Corporation 16k $77k 0% Dec 2025
 View chart
Dimensional Fund Advisors 14k $66k 0% Dec 2025
 View chart
Heron Bay Capital Management 14k $66k 100% Dec 2025
 View chart
Elkhorn Partners Limited Partnership 13k $59k -14% Sep 2025
 View chart
Centiva Capital 11k $53k 100% Dec 2025
 View chart
Northern Trust 11k $53k 100% Dec 2025
 View chart
Kestra Advisory Services 6.0k $29k 100% Dec 2025
 View chart
Advisor Group Holdings 1.6k $7.9k 829% Dec 2025
 View chart
SageView Advisory Group 590.00 $2.9k 100% Dec 2025
 View chart
Harbour Investments 50.00 $244.000000 100% Dec 2025
 View chart
Jones Financial Companies, L.L 31.00 $151.001000 0% Dec 2025
 View chart
Goss Wealth Management 27.00 $132.000300 100% Dec 2025
 View chart
Royal Bank of Canada 2.00 $0 0% Sep 2025
 View chart

Who sold out of Nephros?

Fund or Company Name Date Sold Shares Held Valued At
Susquehanna International Sep 2025 10k $49k
Barclays Sep 2025 106.00 $500.998400
UBS Group Sep 2025 66.00 $312.001800